4
Total investments
0
Early stage
1
Mid stage
0
Late stage
8y
Years active
Portfolio
3 investments Β· sorted by recency
All investments
Early stage
Mid stage
Late stage
Experience Β· 6 entries
All (6)
Investments (4)
2022
2020
Strategy, Finance, New Ventures
2020
bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures.
We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Our platform has the potential to unlock a new generation of medicines.
Our io Cells research products provide scientists access to highly characterised, consistent, scalable human cells that enable research and drug discovery teams to accelerate their experimental timelines and reduce experimental variability, providing an important alternative to traditional workflows. We are also leveraging our platform to build a pipeline of txCells for cell therapies.
To achieve our goals, we have assembled a team of pioneers in stem cell biology, cell programming, mathematical modelling and cell therapy. We are empirical, highly ambitious and driven by a shared vision.
Collaboration is at the heart of bit.bio. Join us on our journey.
For more information on bit.bioβs trademarks, visit www.bit.bio/trademarks
2019
2018
Investor
2018
Techstars helps founders scale their startups into world-changing businesses.
Founded in 2006, Techstars is on a mission to invest in startups to enable more capital to flow to more entrepreneurs around the world in order to deliver exceptional returns to our investors. We do this by operating accelerator programs and venture capital funds, as well as by connecting startups, investors, corporations, and cities to help build thriving startup communities.
Our results show why Techstars is Better for Founders than any other global accelerator: On average, 74.5% of Techstars companies will raise money within 3 years of their program; 18.5% of Techstars portfolio companies have exited 5 years after their program and 31.1% after eight years. (PitchBook June 2023)
Show all 6 entries β
Investment activity
2018β2022 Β· 4 investments
Recent (last 2 years)Earlier
